The effect of rs2910686 on ERAP2 expression in IBD and epithelial inflammatory response.

Autor: Sæterstad S; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Østvik AE; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Gastroenterology and Hepatology, Clinic of Medicine, St. Olav's University Hospital, Trondheim, Norway., Hansen MD; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Clinic of Laboratory Medicine, St. Olav's University Hospital, Trondheim, Norway., Bruland T; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Gastroenterology and Hepatology, Clinic of Medicine, St. Olav's University Hospital, Trondheim, Norway., van Beelen Granlund A; Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology (NTNU), Trondheim, Norway. atle.granlund@ntnu.no.; Department of Gastroenterology and Hepatology, Clinic of Medicine, St. Olav's University Hospital, Trondheim, Norway. atle.granlund@ntnu.no.; Department of Pathology, St. Olav's University Hospital, Trondheim, Norway. atle.granlund@ntnu.no.; Centre of Molecular Inflammation Research, Norwegian University of Science and Technology (NTNU), Trondheim, Norway. atle.granlund@ntnu.no.

Publikováno v: Journal of translational medicine [J Transl Med] 2024 Aug 09; Vol. 22 (1), pp. 750. Date of Electronic Publication: 2024 Aug 09.

Tofacitinib Downregulates TNF and Poly(I:C)-Dependent MHC-II Expression in the Colonic Epithelium.

Autor: Gopalakrishnan S; Department of Clinical and Molecular Medicine (IKOM), NTNU - Norwegian University of Science and Technology, Trondheim, Norway.; Department of Gastroenterology and Hepatology, Clinic of Medicine, St. Olav's University Hospital, Trondheim, Norway., Hansen MD; Department of Clinical and Molecular Medicine (IKOM), NTNU - Norwegian University of Science and Technology, Trondheim, Norway.; Clinic of Laboratory Medicine, St. Olav's University Hospital, Trondheim, Norway., Skovdahl HK; Department of Clinical and Molecular Medicine (IKOM), NTNU - Norwegian University of Science and Technology, Trondheim, Norway.; Centre of Molecular Inflammation Research (CEMIR), NTNU - Norwegian University of Science and Technology, Trondheim, Norway., Roseth IA; Department of Clinical and Molecular Medicine (IKOM), NTNU - Norwegian University of Science and Technology, Trondheim, Norway., van Beelen Granlund A; Department of Clinical and Molecular Medicine (IKOM), NTNU - Norwegian University of Science and Technology, Trondheim, Norway.; Department of Gastroenterology and Hepatology, Clinic of Medicine, St. Olav's University Hospital, Trondheim, Norway.; Centre of Molecular Inflammation Research (CEMIR), NTNU - Norwegian University of Science and Technology, Trondheim, Norway., Østvik AE; Department of Clinical and Molecular Medicine (IKOM), NTNU - Norwegian University of Science and Technology, Trondheim, Norway.; Department of Gastroenterology and Hepatology, Clinic of Medicine, St. Olav's University Hospital, Trondheim, Norway., Bakke I; Department of Clinical and Molecular Medicine (IKOM), NTNU - Norwegian University of Science and Technology, Trondheim, Norway.; Clinic of Laboratory Medicine, St. Olav's University Hospital, Trondheim, Norway., Sandvik AK; Department of Clinical and Molecular Medicine (IKOM), NTNU - Norwegian University of Science and Technology, Trondheim, Norway.; Department of Gastroenterology and Hepatology, Clinic of Medicine, St. Olav's University Hospital, Trondheim, Norway.; Centre of Molecular Inflammation Research (CEMIR), NTNU - Norwegian University of Science and Technology, Trondheim, Norway., Bruland T; Department of Clinical and Molecular Medicine (IKOM), NTNU - Norwegian University of Science and Technology, Trondheim, Norway.; Department of Gastroenterology and Hepatology, Clinic of Medicine, St. Olav's University Hospital, Trondheim, Norway.

Publikováno v: Frontiers in immunology [Front Immunol] 2022 May 17; Vol. 13, pp. 882277. Date of Electronic Publication: 2022 May 17 (Print Publication: 2022).

Pathogenesis of Microscopic Colitis: A Systematic Review.

Autor: Zabana Y; Gastroenterology Department, Hospital Universitari Mútua de Terrassa, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain., Tontini G; Department of Pathophysiology and Transplantation, University of Milan and Gastroenterology and Endoscopy Unit, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, Milan, Italy., Hultgren-Hörnquist E; School of Medical Sciences, Örebro University, Örebro, Sweden., Skonieczna-Żydecka K; Department of Biochemical Sciences, Pomeranian Medical University, Szczecin, Poland., Latella G; Gastroenterology Unit, Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy., Østvik AE; Department of Clinical and Molecular Medicine [IKOM], Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Norway.; Department of Gastroenterology and Hepatology, Clinic of Medicine, St. Olav's University Hospital, Trondheim, Norway., Marlicz W; Department of Gastroenterology, Pomeranian Medical University, Szczecin, Poland.; Centre for Digestive Diseases Endoklinika, Szczecin, Poland., D'Amato M; Gastrointestinal Genetics Lab, CIC bioGUNE - BRTA, Derio, Spain.; Ikerbasque, Basque Foundation for Science, Bilbao, Spain., Arias A; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain.; Research Unit, Hospital General Mancha Centro, Alcázar de San Juan, Ciudad Real, Spain., Mielhke S; Centre for Digestive Diseases, Internal Medicine Centre Eppendorf & Endoscopy Centre, University Hospital Hamburg Eppendorf, Hamburg, Germany., Münch A; Department of Health, Medicine, and Caring Sciences, Linköping University, Linköping, Sweden., Fernández-Bañares F; Gastroenterology Department, Hospital Universitari Mútua de Terrassa, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain., Lucendo AJ; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Barcelona, Spain.; Gastroenterology Department, Hospital General de Tomelloso-Spain and Instituto de Investigación Sanitaria Princesa [IIS-IP], Madrid, Spain.

Publikováno v: Journal of Crohn's & colitis [J Crohns Colitis] 2022 Jan 28; Vol. 16 (1), pp. 143-161.

Mucosal and faecal neutrophil gelatinase-associated lipocalin as potential biomarkers for collagenous colitis.

Autor: Bakke I; Department of Clinical and Molecular Medicine (IKOM), Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, Prinsesse Kristinas Gate 1, 7489, Trondheim, Norway.; Clinic of Laboratory Medicine, St. Olav's University Hospital, Trondheim, Norway., Walaas GA; Department of Clinical and Molecular Medicine (IKOM), Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, Prinsesse Kristinas Gate 1, 7489, Trondheim, Norway., Bruland T; Department of Clinical and Molecular Medicine (IKOM), Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, Prinsesse Kristinas Gate 1, 7489, Trondheim, Norway.; Clinic of Medicine, St. Olav's University Hospital, Trondheim, Norway., Røyset ES; Department of Clinical and Molecular Medicine (IKOM), Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, Prinsesse Kristinas Gate 1, 7489, Trondheim, Norway.; Clinic of Laboratory Medicine, St. Olav's University Hospital, Trondheim, Norway.; Department of Pathology, Clinic of Laboratory Medicine, St. Olav's University Hospital, Trondheim, Norway., van Beelen Granlund A; Department of Clinical and Molecular Medicine (IKOM), Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, Prinsesse Kristinas Gate 1, 7489, Trondheim, Norway.; Centre of Molecular Inflammation Research (CEMIR), Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, Prinsesse Kristinas Gate 1, 7489, Trondheim, Norway., Escudero-Hernández C; Department of Biomedical and Clinical Sciences (BVK), Linköping University, Linköping, Sweden.; Institute of Clinical Molecular Biology (IKMB), Christian-Albrechts-University Kiel, and University Hospital Schleswig Holstein, Kiel, Germany., Thorsvik S; Department of Clinical and Molecular Medicine (IKOM), Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, Prinsesse Kristinas Gate 1, 7489, Trondheim, Norway.; Clinic of Medicine, St. Olav's University Hospital, Trondheim, Norway.; Department of Gastroenterology and Hepatology, Clinic of Medicine, St. Olav's University Hospital, Trondheim, Norway., Münch A; Department of Biomedical and Clinical Sciences (BVK), Linköping University, Linköping, Sweden.; Division of Gastroenterology and Hepatology, Linköping University Hospital, Linköping, Sweden., Sandvik AK; Department of Clinical and Molecular Medicine (IKOM), Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, Prinsesse Kristinas Gate 1, 7489, Trondheim, Norway.; Clinic of Medicine, St. Olav's University Hospital, Trondheim, Norway.; Centre of Molecular Inflammation Research (CEMIR), Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, Prinsesse Kristinas Gate 1, 7489, Trondheim, Norway.; Department of Gastroenterology and Hepatology, Clinic of Medicine, St. Olav's University Hospital, Trondheim, Norway., Østvik AE; Department of Clinical and Molecular Medicine (IKOM), Faculty of Medicine and Health Sciences, NTNU-Norwegian University of Science and Technology, Prinsesse Kristinas Gate 1, 7489, Trondheim, Norway. ann.e.ostvik@ntnu.no.; Clinic of Medicine, St. Olav's University Hospital, Trondheim, Norway. ann.e.ostvik@ntnu.no.; Department of Gastroenterology and Hepatology, Clinic of Medicine, St. Olav's University Hospital, Trondheim, Norway. ann.e.ostvik@ntnu.no.

Publikováno v: Journal of gastroenterology [J Gastroenterol] 2021 Oct; Vol. 56 (10), pp. 914-927. Date of Electronic Publication: 2021 Aug 19.

The Water Channel Aquaporin 8 is a Critical Regulator of Intestinal Fluid Homeostasis in Collagenous Colitis.

Autor: Escudero-Hernández C; Department of Biomedical and Clinical Sciences [BKV), Linköping University, Linköping, Sweden., Münch A; Department of Biomedical and Clinical Sciences [BKV), Linköping University, Linköping, Sweden.; Division of Gastroenterology and Hepatology, Department of Biomedical and Clinical Sciences [BKV), Faculty of Health Science, Linköpings University, Linköping, Sweden., Østvik AE; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Department of Gastroenterology and Hepatology, St Olav's University Hospital, Trondheim, Norway.; Clinic of Medicine, St Olav's University Hospital, Trondheim, Norway., Granlund AVB; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway.; Clinic of Medicine, St Olav's University Hospital, Trondheim, Norway.; Centre of Molecular Inflammation Research, Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology (NTNU), Trondheim, Norway., Koch S; Department of Biomedical and Clinical Sciences [BKV), Linköping University, Linköping, Sweden.; Wallenberg Centre for Molecular Medicine (WCMM), Linköping University, Linköping, Sweden.

Publikováno v: Journal of Crohn's & colitis [J Crohns Colitis] 2020 Jul 30; Vol. 14 (7), pp. 962-973.